drugset / Trial / NCT00664378

Efficacy Study of CYT997 in Multiple Myeloma

NCT00664378 ↗

Phase 2 Terminated 5 enrolled Gilead Sciences
NaSingle-groupOpen-labelTreatment

Summary

This is a clinical research study that is designed to test the safety of CYT997 when given to patients with multiple myeloma and to test if CYT997 has any activity against that cancer.

Timeline

Start
2008-01
Primary completion
2011-02
Completion
2011-02

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty enrolling patients”

Drugs

EvaluationDrugModalityDoseRoute
Subject LEXIBULIN Small molecule 202 mg/m2 Intravenous